↓ Skip to main content

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung…

Overview of attention for article published in Cancer Research and Treatment : Official Journal of Korean Cancer Association, November 2014
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Published in
Cancer Research and Treatment : Official Journal of Korean Cancer Association, November 2014
DOI 10.4143/crt.2014.051
Pubmed ID
Authors

Dae Ho Lee, Jung Shin Lee, Jie Wang, Te-Chun Hsia, Xin Wang, Jongseok Kim, Mauro Orlando

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 20%
Student > Master 9 20%
Other 4 9%
Researcher 4 9%
Student > Ph. D. Student 4 9%
Other 5 11%
Unknown 10 22%
Readers by discipline Count As %
Medicine and Dentistry 11 24%
Nursing and Health Professions 8 18%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Psychology 2 4%
Other 5 11%
Unknown 12 27%